Total: 2 |
|
PMID (PMCID) | ||
---|---|---|
25654378 (4602716) |
FEMALE | |
Long-term cancer-free survival after infusion of autologous cord blood cells for rejection-unrelated cord blood graft after myeloablative conditioning for t-MDS: a case report. | ||
Chen WT, Fang LH, Chen RL. Medicine (Baltimore). 2015;94(5):e438. |
||
We report a case of therapy-related myelodysplasia after metastatic neuroblastoma who suffered from graft rejection and life-threatening infections after a myeloablative unrelated cord blood transplantation. | ||
12847321 |
MIXED_SAMPLE | Infant |
Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma. | ||
Weiss B, Vora A, Huberty J, Hawkins RA, Matthay KK. J Pediatr Hematol Oncol. 2003;25(7):543-7. |
||
Of 95 children with refractory neuroblastoma treated with 131I-MIBG at UCSF, 3 have been identified with secondary myelodysplasia/leukemia. |